439 related articles for article (PubMed ID: 10914612)
41. Hormone replacement therapy trials: an update.
Duvernoy CS; Mosca L
Curr Atheroscler Rep; 2002 Mar; 4(2):156-60. PubMed ID: 11822980
[TBL] [Abstract][Full Text] [Related]
42. Phytoestrogens and breast cancer risk: review of the epidemiological evidence.
Peeters PH; Keinan-Boker L; van der Schouw YT; Grobbee DE
IARC Sci Publ; 2002; 156():331-6. PubMed ID: 12484200
[No Abstract] [Full Text] [Related]
43. Isoflavones and women's health.
Powles T
Breast Cancer Res; 2004; 6(3):140-2. PubMed ID: 15084236
[TBL] [Abstract][Full Text] [Related]
44. [Did the decrease in use of menopausal hormone therapy induce a decrease in the incidence of breast cancer in France (and elsewhere)?].
Ringa V; Fournier A
Rev Epidemiol Sante Publique; 2008 Oct; 56(5):297-301. PubMed ID: 18947946
[No Abstract] [Full Text] [Related]
45. Soy phytoestrogens: research on benefits and risks.
Wagner JD; Anthony MS; Cline JM
Clin Obstet Gynecol; 2001 Dec; 44(4):843-52. PubMed ID: 11600865
[No Abstract] [Full Text] [Related]
46. Managing menopausal problems.
Cobleigh MA
Cancer Treat Res; 2000; 103():1-23. PubMed ID: 10948439
[No Abstract] [Full Text] [Related]
47. Phytoestrogens as therapeutic alternatives to traditional hormone replacement in postmenopausal women.
Umland EM; Cauffield JS; Kirk JK; Thomason TE
Pharmacotherapy; 2000 Aug; 20(8):981-90. PubMed ID: 10939560
[No Abstract] [Full Text] [Related]
48. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
49. Managing the menopause: phyto-oestrogens or hormone replacement therapy?
Eden JA
Ann Med; 2001 Feb; 33(1):4-6. PubMed ID: 11310938
[TBL] [Abstract][Full Text] [Related]
50. [Use of phytoestrogens in medicine].
Tutel'ian VA; Pavliuchkova MS; Pogozheva AV; Derbeneva SA
Vopr Pitan; 2003; 72(2):48-54. PubMed ID: 12924211
[TBL] [Abstract][Full Text] [Related]
51. [Estrogens, progestins and cancer of the endometrium].
Laffargue F; Daures JP
Rev Prat; 1993 Dec; 43(20):2603-9. PubMed ID: 8146558
[TBL] [Abstract][Full Text] [Related]
52. Soy isoflavones--benefits and risks from nature's selective estrogen receptor modulators (SERMs).
Setchell KD
J Am Coll Nutr; 2001 Oct; 20(5 Suppl):354S-362S; discussion 381S-383S. PubMed ID: 11603644
[TBL] [Abstract][Full Text] [Related]
53. An explanation, please!
Cheifitz RL
S Afr Med J; 2002 Apr; 92(4):250-1; author reply 251. PubMed ID: 12056343
[No Abstract] [Full Text] [Related]
54. Soy consumption alters endogenous estrogen metabolism in postmenopausal women.
Xu X; Duncan AM; Wangen KE; Kurzer MS
Cancer Epidemiol Biomarkers Prev; 2000 Aug; 9(8):781-6. PubMed ID: 10952094
[TBL] [Abstract][Full Text] [Related]
55. [Hormonal therapy (HRT) in menopause].
Ciszek-Doniec V
Przegl Lek; 1999; 56(4):308-12. PubMed ID: 10494170
[TBL] [Abstract][Full Text] [Related]
56. Phytoestrogens and menopause. Published evidence supports a role for phytoestrogens in menopause.
Husband AJ
BMJ; 2002 Jan; 324(7328):52. PubMed ID: 11777814
[No Abstract] [Full Text] [Related]
57. [The molecular mechanisms of estrogens. Clinical aspects, industrial estrogens and phytoestrogens].
Hagen ML; Hellmers M; Abrahamsen B; Hagen C
Ugeskr Laeger; 2004 Mar; 166(13):1220-4. PubMed ID: 15088482
[No Abstract] [Full Text] [Related]
58. Easing menopausal symptoms with dietary phytoestrogens.
Brewer S
Community Nurse; 2000 Jul; 6(6):13-5. PubMed ID: 12778644
[No Abstract] [Full Text] [Related]
59. Natural options for menopause.
Norling S
Minn Med; 1999 May; 82(5):42-4. PubMed ID: 10337138
[No Abstract] [Full Text] [Related]
60. Endocrine modulation and the fragile balance of homeostasis--an overview.
Vollmer G; Starcke S; Wober J; Zierau O
Neuro Endocrinol Lett; 2002 Jul; 23 Suppl 2():37-42. PubMed ID: 12163846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
